{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:35:15Z","timestamp":1787740515790,"version":"build-2784847793"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jacl.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T01:04:51Z","timestamp":1699664691000},"page":"828-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6910-5551","authenticated-orcid":false,"given":"Anurag","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Alebna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowtham R.","family":"Grandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-9521","authenticated-orcid":false,"given":"Dave L.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi N.","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2023.09.003_bib0001","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2023.09.003_bib0002","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2023.09.003_bib0003","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of NAFLD and NASH","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacl.2023.09.003_bib0004","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.09.003_bib0005","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11745-010-3408-1","article-title":"Atherogenic dyslipidemia: cardiovascular risk and dietary intervention","volume":"45","author":"Musunuru","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.jacl.2023.09.003_bib0006","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.09.003_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2016.07.003","article-title":"Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults","volume":"461","author":"Nam","year":"2016","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.jacl.2023.09.003_bib0008","doi-asserted-by":"crossref","first-page":"e00504","DOI":"10.14309\/ctg.0000000000000504","article-title":"The ability of lipoprotein (a)level to predict early carotid atherosclerosis is impaired in patients with advanced liver fibrosis related to metabolic-associated fatty liver disease","volume":"13","author":"Wu","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jacl.2023.09.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275901","article-title":"A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity","volume":"17","author":"Hagemann","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacl.2023.09.003_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/hep4.1830","article-title":"Low Lipoprotein(a) levels predict hepatic fibrosis in patients with nonalcoholic fatty liver disease","volume":"6","author":"Meroni","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jacl.2023.09.003_bib0011","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2023.09.003_bib0012","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cca.2014.10.013","article-title":"Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis","volume":"439","author":"Guadagno","year":"2015","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.jacl.2023.09.003_bib0013","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jacl.2023.09.003_bib0014","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jacl.2023.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.510240602","article-title":"Low lipoprotein levels during acute viral hepatitis","volume":"24","author":"Geiss","year":"1996","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jacl.2023.09.003_bib0016","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0149-2918(95)80048-4","article-title":"Lipoprotein(a) concentration in patients with chronic active hepatitis C before and after interferon treatment","volume":"17","author":"Malaguarnera","year":"1995","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacl.2023.09.003_bib0017","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0021-9150(94)90006-X","article-title":"Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis","volume":"105","author":"Gregory","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.09.003_bib0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0009-8981(94)90178-3","article-title":"Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis","volume":"224","author":"Alessandri","year":"1994","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.jacl.2023.09.003_bib0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2022.04.016","article-title":"Lipoprotein and diabetes mellitus","volume":"349","author":"Lamina","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.09.003_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2023.09.003_bib0021","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/dom.14950","article-title":"Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction","volume":"25","author":"Chin","year":"2023","journal-title":"Diabetes Obes Metab"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:39:02Z","timestamp":1761831542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287423002623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1933287423002623"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.09.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}